Roy B. Jones

A randomized phase II study of standard‐dose versus high‐dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B‐cell non‐hodgkin lymphomas: long term results

E. Shpall, Shaoying Li, Y. Nieto, 2017, British journal of haematology.

Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation.

R. Başar, K. Rezvani, D. Marin, 2016, Blood.

Complete remission of psoriasis after autologous hematopoietic stem-cell transplantation for multiple myeloma.

F. Braiteh, S. Giralt, S. Hymes, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas.

E. Shpall, P. Mclaughlin, J. Manning, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Fludarabine with Myeloablative Timed-Sequential Busulfan in Older Patients: Results of a Randomized Phase II Clinical Trial

K. Rezvani, D. Marin, S. Parmar, 2019 .

Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients

K. Rezvani, A. Gaber, D. Marin, 2017, Transplant infectious disease : an official journal of the Transplantation Society.

Altered gene expression in busulfan-resistant human myeloid leukemia.

L. Ramdas, D. Murray, S. Kornblau, 2008, Leukemia research.

Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type

E. Shpall, U. Popat, J. Tarrand, 2010, Haematologica.

A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma.

P. Thall, S. Parmar, E. Shpall, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipients

K. Rezvani, D. Marin, E. Shpall, 2020, Transplant infectious disease : an official journal of the Transplantation Society.

Pure Red Cell Aplasia in Major ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe Pancytopenia.

S. Parmar, E. Shpall, B. Andersson, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Altered gene expression in busulfan-resistant human myeloid leukemia.

L. Ramdas, D. Murray, S. Kornblau, 2008, Leukemia research.